| Useful Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > News and Society > Economics > About Spain, Subtitles, Dubbing and Predicting a Change |
|
Useful Articles - About Spain, Subtitles, Dubbing and Predicting a Change
Some potential changes are not in fact changes yet and the question is: will they ever be? As a foreigner in Spain u According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product sed to read subtitles rather than listen to a voiceover – in case of foreign languages -- you would certainly hope th ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in t they will. A change from dubbing to subtitles would be a welcome one. Spain is not the only Country that favors du lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. bing:
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ertain countries, such as Germany, Italy or Spain, where dubbing has been employed for decades now, seldom accept the d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro use of subtitles, even in modern media such as DVDs where both dubbing and subtitling may be available, other countri ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc es with a similar local-to-import ratios in TV and film production, such as Japan and Romania, have historically favo easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ed subtitles and dubbed screenings are considered childish. writes Wikipedia. Changes normally are i nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically centivated by a trigger, either an external one or a internal one.
Globalisation could provide such a trigger, again and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ on wiki: Globalization refers to the worldwide phenomenon of technological, economic, and cultural change, as bro ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ght about by expanding facilities for intercommunication and interdependency between traditionally isolate cultures.. ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a . One reason why the dubbing process might end one day is the English Language problem that Spain faces. Parent dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod spend fortunes on private tutors for English and other foreign languages. (Although this situation is also changing cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ith the introduction of language projects on schools). Foreign language exposure would certainly benefit (not only) c tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ildren. But will this language reason be strong enough ot produce a change? It is difficult to predict a change, but t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel to give it a go, you should focus on the resistance. Where should that come from? “It's the economy, stupid” Where s ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ubtitles can be produced in a semi-automated way, dubbing is a manual process and if you just think about the number y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products f movies and daily commentaries that require manual elaboration, you will know enough. Behind the dubbing hides a com . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de lete (dubbing) industry. So in order to produce a change in this area, you would need more triggers. Or just take to elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip dubbing for granted as you are only representing a minority group in Spain, no real stakeholder in the change process tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Online Business Tools-Web Conferencing Solutions Good Debt Vs. Bad Debt: What You Need to Know!
|